Noggin (NOG) (NM_005450) Human Recombinant Protein
CAT#: TP762701
Purified recombinant protein of Human noggin (NOG), 28Gln-End, with N-terminal His tag, expressed in E.coli, 50ug
Need it in bulk or customized? Get a free quote |
CNY 2,480.00
货期*
现货
规格
经常一起买 (1)
Noggin (Noggin) mouse monoclonal antibody, clone OTI1H8 (formerly 1H8)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Species | Human |
Expression Host | E. coli |
Expression cDNA Clone or AA Sequence |
A DNA sequence encoding the region (28Gln-End) of NOG
|
Tag | N-His |
Predicted MW | 25.4 kDa |
Concentration | >0.05 ug/ul as determined by microplate BCA method |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | 50mM Tris, pH8.0, 8M Urea |
Storage | Store at -80°C after receiving vials. |
Stability | Stable for at least 1 year from receipt of products under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Reference Data | |
RefSeq | NP_005441 |
Locus ID | 9241 |
UniProt ID | Q13253 |
Refseq Size | 1892 |
Cytogenetics | 17q22 |
Refseq ORF | 696 |
Synonyms | SYM1; SYNS1; SYNS1A |
Summary | The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients. The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as this gene. All of these mutations altered evolutionarily conserved amino acid residues. The amino acid sequence of this human gene is highly homologous to that of Xenopus, rat and mouse. [provided by RefSeq, Jul 2008] |
Protein Families | Druggable Genome, Secreted Protein |
Protein Pathways | TGF-beta signaling pathway |
Documents
FAQs |
SDS |
Customer
Reviews
Loading...